129 related articles for article (PubMed ID: 37728419)
1. Three-Dimensional Chromosomal Landscape Revealing miR-146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR-Mediated Approach to Inhibit the Interferon Pathway.
Zhu X; Zhang Y; Yin Z; Ye Z; Qin Y; Cheng Z; Shen Y; Yin Z; Ma J; Tang Y; Ding H; Guo Y; Hou G; Shen N
Arthritis Rheumatol; 2024 Mar; 76(3):384-395. PubMed ID: 37728419
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
[TBL] [Abstract][Full Text] [Related]
3. SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.
Hou G; Harley ITW; Lu X; Zhou T; Xu N; Yao C; Qin Y; Ouyang Y; Ma J; Zhu X; Yu X; Xu H; Dai D; Ding H; Yin Z; Ye Z; Deng J; Zhou M; Tang Y; Namjou B; Guo Y; Weirauch MT; Kottyan LC; Harley JB; Shen N
Nat Commun; 2021 Jan; 12(1):135. PubMed ID: 33420081
[TBL] [Abstract][Full Text] [Related]
4. Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus.
Hai-yan W; Yang L; Mei-hong C; Hui Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):185-8. PubMed ID: 21529448
[TBL] [Abstract][Full Text] [Related]
5. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.
Luo X; Yang W; Ye DQ; Cui H; Zhang Y; Hirankarn N; Qian X; Tang Y; Lau YL; de Vries N; Tak PP; Tsao BP; Shen N
PLoS Genet; 2011 Jun; 7(6):e1002128. PubMed ID: 21738483
[TBL] [Abstract][Full Text] [Related]
6. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus.
El-Akhras BA; Talaat RM; El-Masry SA; Bassyouni IH; El-Sayed IH; Ali YB
Int J Immunopathol Pharmacol; 2023; 37():3946320231154998. PubMed ID: 36740569
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-98-5p Inhibits IFI44L-Mediated Differentiation of Dendritic Cells and Activation of Interferon Pathway in Systemic Lupus Erythematosus.
Huang X; Tan Y; Wu R; Li Q; Luo S
Immunol Invest; 2024 Apr; 53(3):475-489. PubMed ID: 38198612
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
[TBL] [Abstract][Full Text] [Related]
10. Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity.
Ibrahim MRK; Waly NG; Moness H; Ahmed SS; Ibrahem R
Mol Biol Rep; 2023 Dec; 50(12):10025-10036. PubMed ID: 37904010
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
Sun H; Guo F; Xu L
J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
[TBL] [Abstract][Full Text] [Related]
12. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
[TBL] [Abstract][Full Text] [Related]
13. Relationship of miRNA-146a to primary Sjögren's syndrome and to systemic lupus erythematosus: a meta-analysis.
Sun HY; Lv AK; Yao H
Rheumatol Int; 2017 Aug; 37(8):1311-1316. PubMed ID: 28573480
[TBL] [Abstract][Full Text] [Related]
14. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.
Guo G; Wang H; Shi X; Ye L; Wu K; Lin K; Ye S; Li B; Zhang H; Lin Q; Ye S; Xue X; Chen C
J Transl Med; 2018 Dec; 16(1):370. PubMed ID: 30577810
[TBL] [Abstract][Full Text] [Related]
15. miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA.
Yuan S; Tang C; Chen D; Li F; Huang M; Ye J; He Z; Li W; Chen Y; Lin X; Wang X; Cai X
J Immunol Res; 2019; 2019():9827574. PubMed ID: 31886314
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated miR-146a expression with increased neutrophil extracellular traps and apoptosis formation in autoimmune-mediated diffuse alveolar hemorrhage.
Hsieh YT; Chou YC; Kuo PY; Tsai HW; Yen YT; Shiau AL; Wang CR
J Biomed Sci; 2022 Aug; 29(1):62. PubMed ID: 36028828
[TBL] [Abstract][Full Text] [Related]
17. Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosus.
Dominguez-Gutierrez PR; Ceribelli A; Satoh M; Sobel ES; Reeves WH; Chan EK
J Clin Immunol; 2014 Feb; 34(2):171-80. PubMed ID: 24292724
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microRNA-448 suppresses CD4
Zhang J; Guo Y; Sun Y; Chang L; Wang X
Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
[TBL] [Abstract][Full Text] [Related]
20. Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus.
Hou G; Zhou T; Xu N; Yin Z; Zhu X; Zhang Y; Cui Y; Ma J; Tang Y; Cheng Z; Shen Y; Chen Y; Zou LH; Wang YF; Yin Z; Guo Y; Ding H; Ye Z; Shen N
Arthritis Rheumatol; 2023 Apr; 75(4):574-585. PubMed ID: 36245280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
